When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered ...

Epstein-Barr virus (EBV) has long been postulated to play a role in the pathogenesis of MS, but that connection received a solid boost in 2022, when Alberto Ascherio, MD, DrPH, of Harvard T. H ...

The pathogenesis of MS consists of two arms: an inflammatory arm, which is associated with a potent cellular and humoral immune response against potential CNS antigen (s), and a neurodegenerative ...

A study led by Stanford Medicine researchers proves that EBV triggers multiple sclerosis by priming the immune system to attack the body’s nervous system. This research paper aims to provide an ...

Multiple sclerosis is a chronic disease of the central nervous system (CNS). As an unpredictable disease that affects people differently, some patients with multiple sclerosis may only have mild ...

Cognitive impairment is a recognized sequela of the demyelinating disorder multiple sclerosis (MS). Various studies have attempted to quantify the percentage of patients with cognitive impairment in ...

Glia-enriched cultures from a primary progressive multiple sclerosis iPSC line showing astrocytes (yellow), oligodendrocytes (cyan), and neurons (magenta). [New York Stem Cell Foundation] ...

References Bjornevik K, Cortese M, Healy BC, et al. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science. 2022;375 (6578):296-301.

JOURNAL NAME: Open Journal of Internal Medicine, Vol.14 No.2, June 20, 2024 ABSTRACT: This study was an attempt to examine the effective factors of the Multiple Sclerosis diseases. The participants of ...

Power to establish MS associations at -log_p>7.3 outside of HLA is inadequate in the available MVP data release. Some S/CLE loci appear to be disease specific and may not be involved in MS ...